Acrinova AB Series B
Acrinova AB (publ), a real estate company, owns, develops, and manages real estate properties in Sweden. It offers residential properties, offices, and logistics/production properties. The company was incorporated in 2014 and is headquartered in Malmö, Sweden.
Acrinova AB Series B (ACRI-B) - Total Liabilities
Latest total liabilities as of September 2025: Skr472.42 Million SEK
Based on the latest financial reports, Acrinova AB Series B (ACRI-B) has total liabilities worth Skr472.42 Million SEK as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Acrinova AB Series B - Total Liabilities Trend (2014–2024)
This chart illustrates how Acrinova AB Series B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Acrinova AB Series B Competitors by Total Liabilities
The table below lists competitors of Acrinova AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Evermore Chemical Industry Co Ltd
TW:1735
|
Taiwan | NT$1.65 Billion |
|
Wellbiotec Co. Ltd.
KO:010600
|
Korea | ₩11.76 Billion |
|
Bo Lak
KO:002760
|
Korea | ₩10.77 Billion |
|
Romsdal Sparebank
OL:ROMSB
|
Norway | Nkr7.12 Billion |
|
Caprice Resources Limited
F:C3F
|
Germany | €375.09K |
|
Panagene Inc
KQ:046210
|
Korea | ₩24.65 Billion |
|
Daebo Magnetic Co.Ltd
KQ:290670
|
Korea | ₩29.68 Billion |
|
European Lithium Limited
OTCQB:EULIF
|
USA | $113.45 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Acrinova AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Acrinova AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Acrinova AB Series B (2014–2024)
The table below shows the annual total liabilities of Acrinova AB Series B from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr1.23 Billion | +0.81% |
| 2023-12-31 | Skr1.22 Billion | +5.37% |
| 2022-12-31 | Skr1.15 Billion | +20.72% |
| 2021-12-31 | Skr956.25 Million | +77.66% |
| 2020-12-31 | Skr538.24 Million | +30.33% |
| 2019-12-31 | Skr412.98 Million | +51.60% |
| 2018-12-31 | Skr272.41 Million | +16.20% |
| 2017-12-31 | Skr234.44 Million | +16.71% |
| 2016-12-31 | Skr200.88 Million | +1448.74% |
| 2015-12-31 | Skr12.97 Million | -84.72% |
| 2014-12-31 | Skr84.86 Million | -- |